Clinical Research on Preemptive Analgesia of Different doses of Dezocine on Patients Treated with Laparoscopic Gynecological Surgery
Ye Hon
Abstract
Ye Hon
Abstract
Objective: To observe the postoperative analgesia of different doses of dezocine in gynecological laparoscopic operation. Methods: Ninety ASAⅠ-Ⅱ patients aged 20-60 years, undergoing the gynecological laparoscopic operation were randomly divided into three groups, 30 in each group. Patients in group A received dezocine 0.1mg/kg intravenous injection 15 minutes before skin incision; patients in group B received dezocine 0.15mg/kg intravenous injection 15 minutes before skin incision; patients in group C received dezocine 0.2mg/kg intravenous injection 15 minutes before skin incision. The postoperative analgesic effects were estimated by Visual Analogue Scale(VAS). Additional analgesics and adverse effects were recorded. Results: The VAS scores of group B and C were significantly lower than those of group A at 2h, 4h, 6h and 8h after surgery(P0.05). The Ramsay scores of group A and B were significantly higher than those of group C at 2,4 h after surgery(P0.05). The application rate of additional analgesics of group B and C were significantly lower than that of group A(P0.05). No significant difference of the incidence of adverse effects was found among the three groups(P0.05). Conclusion: 0.15mg/kg dezocine intravenous injection 15 minutes before skin incision could provide satisfying postoperative analgesia in patients undergoing gynecological laparoscopic operation and had lower incidence of adverse effects.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To observe the postoperative analgesia of different doses of dezocine in gynecological laparoscopic operation. Methods: Ninety ASAⅠ-Ⅱ patients aged 20-60 years, undergoing the gynecological laparoscopic operation were randomly divided into three groups, 30 in each group. Patients in group A received dezocine 0.1mg/kg intravenous injection 15 minutes before skin incision; patients in group B received dezocine 0.15mg/kg intravenous injection 15 minutes before skin incision; patients in group C received dezocine 0.2mg/kg intravenous injection 15 minutes before skin incision. The postoperative analgesic effects were estimated by Visual Analogue Scale(VAS). Additional analgesics and adverse effects were recorded. Results: The VAS scores of group B and C were significantly lower than those of group A at 2h, 4h, 6h and 8h after surgery(P0.05). The Ramsay scores of group A and B were significantly higher than those of group C at 2,4 h after surgery(P0.05). The application rate of additional analgesics of group B and C were significantly lower than that of group A(P0.05). No significant difference of the incidence of adverse effects was found among the three groups(P0.05). Conclusion: 0.15mg/kg dezocine intravenous injection 15 minutes before skin incision could provide satisfying postoperative analgesia in patients undergoing gynecological laparoscopic operation and had lower incidence of adverse effects.
Key concepts: Dezocine, Medicine, Anesthesia, Analgesic, Adverse effect, Surgery, Visual analogue scale, Laparoscopic surgery